Literature DB >> 26085198

Clinical research on intelligence seven needle therapy treated infants with brain damage syndrome.

Zhen-Huan Liu1, Ye-Rong Li2, Yong-Lin Lu2, Jie-Kui Chen3.   

Abstract

OBJECTIVE: To assess whether the intelligence seven needle therapy administered in infants with perinatal brain damage syndrome (BDS) as early intervention would improve patients' neural development.
METHODS: A randomized controlled trial was conducted. Sixty-four infants with BDS were randomly assigned to two groups: the comprehensive group and the control group. Both groups received routine early intervention; in addition, the comprehensive group received intelligence seven needle therapy. Before and after treatment, the Bayley Scale of Infant Development (BSID), Gesell Developmental Schedules, Gross Motor Function Measure (GMFM), transcranial doppler ultrasound (TCD), and cranial imaging examination were tested for contrast.
RESULTS: After treatment, the comprehensive group showed significant difference in the Mental Development Index (MDI) scores of BSID compared with the control group (P<0.05), however, no significant discrepancy in psychomotor development index (PDI,P>0.05) was observed. The children's development quotients (DQ) of the comprehensive group exhibited a significant superiority in improving the social adaptation DQ of Gesell Developmental Schedules compared with the control group (P<0.01), as well as GMFM and linguistic and social intercourse (P<0.05). Again, no discrepancy in the fine movement DQ was found (P>0.05). The total scores of GMFM in the comprehensive group were higher than those in the control group (P<0.05). Comparing the two groups, the comprehensive group showed a significantly greater recovery rate than the control group on TCD after treatment (P<0.05). After 6-month follow-up, some recovery in both groups, specifically on broadening of brain outside space by cranial imaging examination were observed. The comprehensive group demonstrated a significantly greater recovery rate than the control group (P<0.05).
CONCLUSION: The developmental level of intelligence, motion function, linguistic competence and social intercourse can be promoted for infants with perinatal BDS by treating with the intelligence seven needle therapy. This approach can improve the brain blood supply and promote the growth of frontal and parietal lobes.

Entities:  

Keywords:  acupuncture; brain damage syndrome; early intervention; intelligence seven needle therapy

Mesh:

Year:  2015        PMID: 26085198     DOI: 10.1007/s11655-015-1977-9

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  5 in total

Review 1.  A systematic review of the effects of early intervention on motor development.

Authors:  Cornill H Blauw-Hospers; Mijna Hadders-Algra
Journal:  Dev Med Child Neurol       Date:  2005-06       Impact factor: 5.449

2.  Intervention for infants with brain injury: results of a randomized controlled study.

Authors:  Lina Kurdahi Badr; Meena Garg; Meghna Kamath
Journal:  Infant Behav Dev       Date:  2005-08-31

3.  [Clinical observation on children with language disorder of cerebral palsy treated by acupuncture].

Authors:  Quan-Ming Zhang; Rui Jin
Journal:  Zhongguo Zhen Jiu       Date:  2005-10

4.  Early physical therapy effects on the high-risk infant: a randomized controlled trial.

Authors:  M C Piper; V I Kunos; D M Willis; B L Mazer; M Ramsay; K M Silver
Journal:  Pediatrics       Date:  1986-08       Impact factor: 7.124

5.  Comparison of enrollment in interventional therapies between late-preterm and very preterm infants at 12 months' corrected age.

Authors:  Jessica L Kalia; Paul Visintainer; Heather L Brumberg; Maria Pici; Jordan Kase
Journal:  Pediatrics       Date:  2009-03       Impact factor: 7.124

  5 in total
  1 in total

1.  Adverse Associations of both Prenatal and Postnatal Exposure to Organophosphorous Pesticides with Infant Neurodevelopment in an Agricultural Area of Jiangsu Province, China.

Authors:  Ping Liu; Chunhua Wu; Xiuli Chang; Xiaojuan Qi; Minglan Zheng; Zhijun Zhou
Journal:  Environ Health Perspect       Date:  2016-05-06       Impact factor: 9.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.